Merck pays $700M for bispecific, spying autoimmune opening and chance to challenge Amgen in cancer 0 09.08.2024 15:18 Fiercebiotech.com Merck pays $700M for bispecific, spying autoimmune opening and chance to challenge Amgen in cancer ntaylor Fri, 08/09/2024 - 08:18
